Recent Finacing
Recent Raise
Monarch Biosciences develops TFN thin‑film nitinol medical devices—including Titan Flow Diverter for cerebral aneurysm occlusion and Engineered Lymph Node for localized cell‑therapy delivery—licensed from UCLA and Fred Hutch.
